Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | HMGB2 |
| Upstream (Parents) |
|---|
| (<<) NR1I3 → HMGB2 |
| (<<) ATF5 → HMGB2 |
| (<<) AR → HMGB2 |
| (<<) E2F8 → HMGB2 |
| (<<) PEG3 → HMGB2 |
| (<<) MYC → HMGB2 |
| Downstream (Children) |
|---|
| HMGB2 → GLI2 (>>) |
| HMGB2 → ZNF135 (>>) |
| HMGB2 → SOX4 (>>) |
| HMGB2 → HOXD1 (>>) |
| HMGB2 → OVOL1 (>>) |
| HMGB2 → ZNF117 (>>) |
| HMGB2 → POU4F3 (>>) |
| HMGB2 → OLIG2 (>>) |
| HMGB2 → MYBL2 (>>) |
| HMGB2 → LEF1 (>>) |
| HMGB2 → NFE2L3 (>>) |
| HMGB2 → FOXM1 (>>) |
| HMGB2 → NKX6-1 (>>) |
| HMGB2 → PTTG1 (>>) |
| HMGB2 → NFIC (>>) |
| HMGB2 → ELK4 (>>) |
| HMGB2 → BCL6 (>>) |
| HMGB2 → EPAS1 (>>) |
| HMGB2 → ZNF202 (>>) |
